SEC Form 4 · accession 0000899243-16-033995
Invuity, Inc. · IVTY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Eric W Roberts
Director
Period of report
Nov 17, 2016
Accepted (ET)
Nov 21, 2016 · 12:54 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001393020
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 17, 2016 | J | 249,632 | $0.00 | D | 0 | I | By Valence CDK |
| Common Stock | Nov 17, 2016 | J | 46,602 | $0.00 | A | 46,602 | I | By Valence |
| Common Stock | holding | — | — | — | 69,945 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1203,030 of the shares were distributed by Valence CDK SPV, L.P. ("Valence CDK") to its sole limited partner and 46,602 of the shares were distributed by Valence CDK to Valence Life Sciences GP II, LLC ("Valence"). The Reporting Person is a Managing Member of Valence, which is the General Partner of Valence CDK. The Reporting Person disclaims beneficial ownership of the shares held by Valence, except to the extent of his pecuniary interest therein.